Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,844 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | NVDA | NVIDIA Corporation | Raymond James | Main | Strong Buy | Strong Buy | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | NVDA | NVIDIA Corporation | Needham | Main | Buy | Buy | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | NVDA | NVIDIA Corporation | Bernstein | Main | Outperform | Outperform | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | NVDA | NVIDIA Corporation | JP Morgan | Main | Overweight | Overweight | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | NVDA | NVIDIA Corporation | Mizuho | Main | Outperform | Outperform | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | NVDA | NVIDIA Corporation | Citigroup | Main | Buy | Buy | Buy | 35 | $257.81 | +18.10% | 4.41T |
| Aug 27, 2026 | OKTA | Okta, Inc. | Bernstein | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | UBS | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Oppenheimer | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Citizens | Main | Market Outperform | Market Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Truist Securities | Reiterated | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | DA Davidson | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Morgan Stanley | Main | Overweight | Overweight | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Guggenheim | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Evercore ISI Group | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Keybanc | Main | Overweight | Overweight | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Barclays | Main | Overweight | Overweight | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Piper Sandler | Main | Neutral | Neutral | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | BTIG | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Needham | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Citigroup | Main | Neutral | Neutral | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | JP Morgan | Main | Overweight | Overweight | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Raymond James | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | B of A Securities | Upgrade | Underperform | Neutral | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Baird | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | BMO Capital | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Jefferies | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | TD Cowen | Main | Hold | Hold | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Mizuho | Main | Neutral | Neutral | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OKTA | Okta, Inc. | Macquarie | Main | Outperform | Outperform | — | — | $108.47 | -34.85% | 15.35B |
| Aug 27, 2026 | OLLI | Ollie's Bargain Outlet Holdings, Inc. | UBS | Main | Neutral | Neutral | Buy | 22 | $142.36 | +93.53% | 7.13B |
| Aug 27, 2026 | OOMA | Ooma, Inc. | B. Riley Securities | Main | Buy | Buy | — | — | $18.00 | -20.95% | 314.5M |
| Aug 27, 2026 | OUST | Ouster, Inc. | Rosenblatt | Main | Buy | Buy | — | — | $36.67 | +3.79% | 1.58B |
| Aug 27, 2026 | OWL | Blue Owl Capital Inc. | Oppenheimer | Main | Outperform | Outperform | Buy | 20 | $20.50 | +94.13% | 25.18B |
| Aug 27, 2026 | PAVM | PAVmed Inc. | Ascendiant Capital | Main | Buy | Buy | — | — | — | — | 6.07M |
| Aug 27, 2026 | PEB | Pebblebrook Hotel Trust | Barclays | Main | Underweight | Underweight | — | — | $12.10 | -32.17% | 1.33B |
| Aug 27, 2026 | PGR | The Progressive Corporation | UBS | Main | Neutral | Neutral | Hold | 17 | $250.90 | +15.29% | 135.08B |
| Aug 27, 2026 | PK | Park Hotels & Resorts Inc. | Barclays | Main | Equal-Weight | Equal-Weight | — | — | $11.75 | -23.10% | 2.16B |
| Aug 27, 2026 | PRE | Prenetics Global Limited | B. Riley Securities | Initiated | — | Buy | — | — | — | — | 203.72M |
| Aug 27, 2026 | PRI | Primerica, Inc. | Truist Securities | Downgrade | Buy | Hold | — | — | $299.00 | +2.24% | 8.16B |
| Aug 27, 2026 | PUMP | ProPetro Holding Corp. | Piper Sandler | Main | Overweight | Overweight | — | — | $12.25 | +6.99% | 1.16B |
| Aug 27, 2026 | PURR | Hyperliquid Strategies Inc Common Stock | Chardan Capital | Main | Buy | Buy | — | — | — | — | 529.29M |
| Aug 27, 2026 | REAX | The Real Brokerage Inc. | BTIG | Main | Buy | Buy | — | — | — | — | 903.24M |
| Aug 27, 2026 | RHP | Ryman Hospitality Properties, Inc. | Barclays | Main | Overweight | Overweight | Buy | 17 | $107.00 | -12.29% | 6.09B |
| Aug 27, 2026 | RLJ | RLJ Lodging Trust | Barclays | Main | Underweight | Underweight | — | — | $7.75 | -28.77% | 1.15B |
| Aug 27, 2026 | RVMD | Revolution Medicines, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $82.00 | -59.76% | 15.18B |
| Aug 27, 2026 | RVMD | Revolution Medicines, Inc. | Oppenheimer | Main | Outperform | Outperform | — | — | $82.00 | -59.76% | 15.18B |
